EichorEICHOR
Condition: Carcinoma Nos Synced from ClinicalTrials.gov · August 06, 2026

Recruiting studies: Carcinoma Nos

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

BP1001-A in Patients With Advanced or Recurrent Solid Tumors
Phase 1 · 4 location(s) · Bio-Path Holdings, Inc. · NCT04196257A Validation Study to Determine Concordance of Liquid Biopsy and Breast Cancer Diagnosis
Phase N/A · 4 location(s) · University of Southern California · NCT06336928Photon Radiotherapy Plus Tremelimumab/Durvalumab for BCLC Stage B and C HCC
Phase 2 · 1 location(s) · Chang Gung Memorial Hospital · NCT06999707Hypofractionated Radiotherapy Combined with Immunotherapy for Limited-stage Small-cell Lung Cancer
Phase 1/Phase 2 · 1 location(s) · Anhui Provincial Hospital · NCT06527898Safety/Efficacy Study of CID-078 in Patients With Advanced Solid Tumor Malignancies
Phase 1 · 10 location(s) · Circle Pharma · NCT06577987An Investigational Scan (Flotufolastat F 18 PET/CT) for Detecting Residual or Recurrent Disease in Patients Who Complete
Phase 2 · 1 location(s) · Jonsson Comprehensive Cancer Center · NCT07185165Tauroursodeoxycholic Acid (TUDCA) Plus Camrelizumab and Regorafenib in Hepatocellular Carcinoma Previously Treated With
Phase 2 · 1 location(s) · Fudan University · NCT07100392A Study of Trastuzumab Deruxtecan in People With Non-Small Cell Lung Cancer
Phase 2 · 10 location(s) · Memorial Sloan Kettering Cancer Center · NCT07428044Evaluation of PreveCol's Efficiency As a Second Line Method for the Early Colorectal Cancer Detection
NA · 2 location(s) · ADVANCED MARKER DISCOVERY S.L. · NCT06703632First-Line and Neoadjuvant Immunotherapy for Gastric Cancer
Phase N/A · 1 location(s) · Qilu Hospital of Shandong University · NCT06727981Early Rebiopsy to Identify Biomarkers of Tumor Cell Survival Following EGFR, ALK, ROS1 or BRAF TKI Therapy
Phase N/A · 1 location(s) · University of Colorado, Denver · NCT03042221Postoperative Radiotherapy for Early-stage Oral Tongue Squamous Cell Carcinoma Patients With Risk Factors: a Prospective
NA · 28 location(s) · Second Affiliated Hospital, Zhejiang University, School of M · NCT07402525Cryoablation Combined With Cardonilizumab and Bevacizumab in Hepatocellular Carcinoma With Pulmonary Metastases
NA · 2 location(s) · Sun Yat-sen University · NCT06265350Pseudovax - A Cancer Vaccine for Patients With Pseudomyxoma Peritonei
EARLY_Phase 1 · 1 location(s) · Oslo University Hospital · NCT07341360Collection of Plasma Samples for Squamous Cell Carcinoma of the Head and Neck Patients
Phase N/A · 5 location(s) · Cliniques universitaires Saint-Luc- Université Catholique de · NCT02139020Neoadjuvant Hypofractionated Stereotactic Body Radiation Therapy Prior to Surgery for Hepatocellular Carcinoma: a Feasib
Phase 1 · 1 location(s) · University Hospital, Lille · NCT04587739Testing the Addition of an Individualized Vaccine to Durvalumab and Tremelimumab and Chemotherapy in Patients With Metas
Phase 2 · 30 location(s) · National Cancer Institute (NCI) · NCT03606967Intravascular Radiofrequency Ablation of Sympathetic Nerves for the Treatment of Hepatocellular Carcinoma
NA · 1 location(s) · Zhongda Hospital · NCT06694636Survival and Prognostic Factors of Squamous Cell Carcinoma of the Nasal Vestibule
Phase N/A · 6 location(s) · Istituto Clinico Humanitas · NCT05693116CT-guided Localization for Micro Hepatocellular Carcinoma Before Surgical Resection
NA · 1 location(s) · Northern Jiangsu People's Hospital · NCT05433467PARa-aOrtic LymphAdenectomy in Locally Advanced Cervical Cancer
Phase 3 · 37 location(s) · Institut Claudius Regaud · NCT05581121AD HOC Trial: Artificial Intelligence-Based Drug Dosing In Hepatocellular Carcinoma
Phase 2 · 1 location(s) · University of Florida · NCT056693395-Azacytidine and/or Nivolumab in Resectable HPV-Associated HNSCC
Phase 2 · 1 location(s) · Barbara Burtness · NCT05317000Understanding Tobacco and Cannabis Co-Use Practices: Initiation, Escalation, and Maintenance
Phase N/A · 1 location(s) · Roswell Park Cancer Institute · NCT07439471Low-Dose Radiation + SBRT + Tislelizumab Plus Platinum-based Chemotherapy in Stage ⅡA-ⅢB Non-small Cell Lung Cancer
Phase 2 · 1 location(s) · Sichuan University · NCT06877299Efficacy and Safety of Activated T Lymphocytes (ATL) in Hepatocellular Carcinoma
Phase 2 · 13 location(s) · Lukas Biomedical Inc. · NCT05304481Collecting Patient-Reported Experiences With Radiation Dermatitis in Breast Cancer Patients Undergoing Radiotherapy
Phase N/A · 1 location(s) · Mayo Clinic · NCT06953245Predicting clinicAL outcoMes During First-line CDK4/6 Inhibitors Plus Endocrine Therapy in Patients With Advanced Hormon
Phase N/A · 24 location(s) · Fondazione IRCCS Istituto Nazionale dei Tumori, Milano · NCT06805812Omitting CTV for Locally Advanced NSCLC Responded to Immunotherapy and Chemotherapy
NA · 1 location(s) · Hubei Cancer Hospital · NCT06020430Delayed Sentinel Lymph Node Biopsy in Ductal Cancer in Situ
Phase 3 · 9 location(s) · Uppsala University · NCT04722692
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →
Eichor
Clinical intelligence from public evidence
Use of Eichor is governed by our Terms of Use · Privacy Policy
© 2026 Biomedistats LLC (dba Eichor)

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.